|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2011-2-1
|
|
pubmed:abstractText |
To test the hypothesis that increased pelvic bone marrow (BM) irradiation is associated with increased hematologic toxicity (HT) in cervical cancer patients undergoing chemoradiotherapy and to develop a normal tissue complication probability (NTCP) model for HT.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1879-355X
|
|
pubmed:author |
pubmed-author:AydoganBulentB,
pubmed-author:BafanaRounakR,
pubmed-author:DandekarViragV,
pubmed-author:HasselleMichael DMD,
pubmed-author:LiangYunY,
pubmed-author:MellLoren KLK,
pubmed-author:MundtArno JAJ,
pubmed-author:RoeskeJohn CJC,
pubmed-author:RoseBrent SBS,
pubmed-author:YasharCatheryn MCM,
pubmed-author:YeginerMeteM
|
|
pubmed:copyrightInfo |
Copyright © 2011 Elsevier Inc. All rights reserved.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
1
|
|
pubmed:volume |
79
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
800-7
|
|
pubmed:dateRevised |
2011-8-1
|
|
pubmed:meshHeading |
pubmed-meshheading:20400238-Antineoplastic Agents,
pubmed-meshheading:20400238-Body Mass Index,
pubmed-meshheading:20400238-Bone Marrow,
pubmed-meshheading:20400238-Cisplatin,
pubmed-meshheading:20400238-Combined Modality Therapy,
pubmed-meshheading:20400238-Female,
pubmed-meshheading:20400238-Hemoglobin A,
pubmed-meshheading:20400238-Humans,
pubmed-meshheading:20400238-Leukocyte Count,
pubmed-meshheading:20400238-Middle Aged,
pubmed-meshheading:20400238-Models, Statistical,
pubmed-meshheading:20400238-Neutrophils,
pubmed-meshheading:20400238-Organs at Risk,
pubmed-meshheading:20400238-Pelvis,
pubmed-meshheading:20400238-Platelet Count,
pubmed-meshheading:20400238-Probability,
pubmed-meshheading:20400238-Radiation Injuries,
pubmed-meshheading:20400238-Radiotherapy, Intensity-Modulated,
pubmed-meshheading:20400238-Radiotherapy Dosage,
pubmed-meshheading:20400238-Uterine Cervical Neoplasms
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Normal tissue complication probability modeling of acute hematologic toxicity in cervical cancer patients treated with chemoradiotherapy.
|
|
pubmed:affiliation |
Department of Radiation Oncology and Center for Advanced Radiotherapy Technologies, University of California, San Diego, La Jolla, CA 92093-0843, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural,
Validation Studies
|
